For CYSLTR1, nuclear receptor staining was also detected in 14/19 ESCC (74 %) as well as in 12/15 non-transformed mucosa specimen of patients with cancer (80 %) and 6/9 in control (66 %). This evidence concerns the gene CYSLTR1 and cancer.